# Ectoin Lozenges (EHT02) in the Treatment of Oropharyngeal Allergic Symptoms

> **NCT03975257** · NA · COMPLETED · sponsor: **Bitop AG** · enrollment: 90 (actual)

## Conditions studied

- Allergy

## Interventions

- **DEVICE:** Medical Device: Ectoin Lozenge

## Key facts

- **NCT ID:** NCT03975257
- **Lead sponsor:** Bitop AG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-04
- **Primary completion:** 2019-09-12
- **Final completion:** 2019-09-12
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2019-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03975257

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03975257, "Ectoin Lozenges (EHT02) in the Treatment of Oropharyngeal Allergic Symptoms". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT03975257. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*